Differentiating MYCN-amplified RB1 wild-type retinoblastoma from biallelic RB1 mutant retinoblastoma using MR-based radiomics: a retrospective multicenter case–control study
- DOI
- 10.1038/s41598-024-76933-6
- Published
- 2024-10-23
- Container
- Scientific Reports
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s41598-024-76933-6,
title = {Differentiating MYCN-amplified RB1 wild-type retinoblastoma from biallelic RB1 mutant retinoblastoma using MR-based radiomics: a retrospective multicenter case–control study},
author = {Christiaan M. de Bloeme and Robin W. Jansen and Liesbeth Cardoen and Sophia Göricke and Sabien van Elst and Jaime Lyn Jessen and Aparna Ramasubramanian and Alison H. Skalet and Audra K. Miller and Philippe Maeder and Ogul E. Uner and G. Baker Hubbard and Hans Grossniklaus and H. Culver Boldt and Kim E. Nichols and Rachel C. Brennan and Saugata Sen and Mériam Koob and Selma Sirin and Hervé J. Brisse and Paolo Galluzzi and Charlotte J. Dommering and Matthijs Cysouw and Ronald Boellaard and Josephine C. Dorsman and Annette C. Moll and Marcus C. de Jong and Pim de Graaf and Unknown},
year = {2024},
journal = {Scientific Reports},
doi = {10.1038/s41598-024-76933-6},
url = {https://doi.org/10.1038/s41598-024-76933-6}
}RIS
TY - JOUR TI - Differentiating MYCN-amplified RB1 wild-type retinoblastoma from biallelic RB1 mutant retinoblastoma using MR-based radiomics: a retrospective multicenter case–control study AU - Christiaan M. de Bloeme AU - Robin W. Jansen AU - Liesbeth Cardoen AU - Sophia Göricke AU - Sabien van Elst AU - Jaime Lyn Jessen AU - Aparna Ramasubramanian AU - Alison H. Skalet AU - Audra K. Miller AU - Philippe Maeder AU - Ogul E. Uner AU - G. Baker Hubbard AU - Hans Grossniklaus AU - H. Culver Boldt AU - Kim E. Nichols AU - Rachel C. Brennan AU - Saugata Sen AU - Mériam Koob AU - Selma Sirin AU - Hervé J. Brisse AU - Paolo Galluzzi AU - Charlotte J. Dommering AU - Matthijs Cysouw AU - Ronald Boellaard AU - Josephine C. Dorsman AU - Annette C. Moll AU - Marcus C. de Jong AU - Pim de Graaf AU - Unknown PY - 2024 JO - Scientific Reports DO - 10.1038/s41598-024-76933-6 UR - https://doi.org/10.1038/s41598-024-76933-6 ER -
APA
Bloeme, C. M. D., Jansen, R. W., Cardoen, L., Göricke, S., Elst, S. V., Jessen, J. L., Ramasubramanian, A., Skalet, A. H., Miller, A. K., Maeder, P., Uner, O. E., Hubbard, G. B., Grossniklaus, H., Boldt, H. C., Nichols, K. E., Brennan, R. C., Sen, S., Koob, M., Sirin, S., Brisse, H. J., Galluzzi, P., Dommering, C. J., Cysouw, M., Boellaard, R., Dorsman, J. C., Moll, A. C., Jong, M. C. D., Graaf, P. D., & Unknown (2024). Differentiating MYCN-amplified RB1 wild-type retinoblastoma from biallelic RB1 mutant retinoblastoma using MR-based radiomics: a retrospective multicenter case–control study. Scientific Reports. https://doi.org/10.1038/s41598-024-76933-6
Source records
- crossref · retrieved 2026-09-25T09:31:14.990Z